Facial Dyskinesia: A 16–Year Follow-up Study
The British Journal of PsychiatryPublished 1 May 1991
H. A. McClelland, A. V. Metcalfe, T. A. Kerr, D. Dutta, Patricia Watson
Citations23
SJR quartileQ1
SJR score2.47
SNIP2.17
Generate an AI Snapshot to get a quick, structured summary of this paper.
Study Snapshot
ObjectiveStudy objective
MethodsResearch methodology
PopulationPopulation studied
Sample sizeSample sizes
OutcomesStudy outcomes here
ResultsStudy results comes here
LimitationsResearch study limitations comes here
A concise AI-generated summary of the paper will appear here once you click Generate AI Snapshot.
TL;DR
The 109 female survivors of a mental hospital population surveyed in 1965 for facial dyskinesia and the 99 survivors with non-organic brain syndromes were analysed and enlarged ventricles on brain scans were significantly associated with dyskineia, cognitive impairment and neuroleptic prescribing.
Abstract
The 109 female survivors of a mental hospital population surveyed in 1965 for facial dyskinesia were followed up 16 years later. The 99 survivors with non-organic brain syndromes were analysed. Prevalence of dyskinesia had risen from 18.4% to 46.5% during follow-up and its development was significantly associated with neuroleptic dosage. Enlarged ventricles on brain scans were significantly associated with dyskinesia, cognitive impairment and neuroleptic prescribing.
Keywords
MedicineNeuroscience
The British Journal of PsychiatryThe Association Between Quantitative Measures of Dementia and of Senile Change in the Cerebral Grey Matter of Elderly Subjects
4,123 Citations1968G. Blessed, B. E. Tomlinson +1 more
The expectation of mental disorder shows a steep increase with advancing chronological age, and beyond 75 years a large part of this increase is accounted for by disorders associated with degenerative changes in the central nervous system for which the authors lack remedies at the present time.
Journal of Psychiatric ResearchDose equivalence of the anti-psychotic drugs
324 Citations1974John M. Davis
This chapter discusses the dose equivalence of the antipsychotic drugs, which provides a major tool for investigation of biochemical theories of mental illness such as the dopamine theory of schizophrenia.
American Journal of PsychiatryTardive dyskinesia: summary of a Task Force Report of the American Psychiatric Association. By the Task Force on Late Neurological Effects of Antipsychotic Drugs
191 Citations1980
An alarmist view is unwarranted, especially since many cases are detected early and improve spontaneously, and there is a search for new agents with much less adverse neurologic effect but with adequate antipsychotic efficacy.
The British Journal of PsychiatryVentricular Enlargement in Schizophrenia
179 Citations1992John D. Van Horn, I. C. McManus
There is a difference in VBR between schizophrenics and controls which would seem to be an indisputable characteristic of schizophrenia, but the difference is probably too small to be of practical significance in diagnosis, or in the differentiation of subtypes.
The British Journal of PsychiatryA Study of Facial Dyskinesia in a Mental Hospital Population
138 Citations1971Sydney Brandon, H. A. McClelland +1 more
Abnormal movements are common and accepted complications of phenothiazine therapy and are usually regarded as of extrapyramidal origin, develop soon after medication is started and are often abolished by stopping the drug or giving specific chemotherapy.
The British Journal of PsychiatryNeuroanatomical Studies of Major Affective Disorders
130 Citations1988Dilip V. Jeste, James B. Lohr +1 more
Computerised tomography studies show that patients with affective disorders tend to be similar to schizophrenic patients and significantly different from normal control subjects in ventricle:brain ratio, sulcal widening, and cerebellar vermian atrophy.
The British Journal of PsychiatryTardive Dyskinesia and Dementia
113 Citations1979O. O. Famuyiwa, D. Eccleston +2 more
It is suggested that the higher incidence of pathology in the tardive dyskinesia group may be related to chronic neuroleptic toxicity.
Schizophrenia BulletinAkinesia, Tardive Dysmentia, and Frontal Lobe Disorder in Schizophrenia
108 Citations1985Elkhonon Goldberg
It is possible that the widely reported "frontal lobe dysfunction" in some chronic schizophrenic patients at least in part reflects iatrogenic changes in the mesolimbic/mesocortical dopamine system, which projects extensively into prefrontal areas.
Psychological MedicineTardive dyskinesia: a 3-year follow-up study
81 Citations1983Thomas R. E. Barnes, T. Kidger +1 more
The amount of purposeless trunk and limb movement present proved to be a relatively stable phenomenon, showing only a slight increase with age and no change over the follow-up period.
Journal of Clinical PsychopharmacologyThe Natural History of Tardive Dyskinesia
80 Citations1988G. Gárdos, Jonathan Cole +4 more
A naturalistic study with pharmacotherapy tailored to the underlying psychiatric disorder and conducted long-term from TD onset is the ideal design for investigating the natural history of tardive dyskinesia.
Journal of Clinical PsychopharmacologyA Prospective Study of Tardive Dyskinesia Development
72 Citations1982John M. Kane, Margaret G. Woerner +3 more
Preliminary findings from a prospective study of tardive dyskinesia development in a population of psychiatric patients suggest a TD incidence of 12% after 4 years of cumulative neuroleptic exposure.
The British Journal of PsychiatryAge Disorientation in Chronic Schizophrenia: The Nature of the Cognitive Deficit
70 Citations1978T. J. Crow, Marilyn Stevens
There appears to be a continuum of increasing temporal disorientation in chronic schizophrenia among patients in whom an incorrect appreciation of their own age co-exists with correct awareness of the present year.
Human Psychopharmacology Clinical and ExperimentalTardive dyskinesia in schizophrenia and other disorders: Associations with ageing, cognitive dysfunction and structural brain pathology in relation to neuroleptic exposure
64 Citations1987John L. Waddington
It is argued from clinical and animal studies that neuroleptics may hasten the appearance of dyskinetic movements in individuals with the greatest likelihood of ultimately having such movements spontaneously as cerebral deterioration proceeds.
Psychopharmacology seriesTardive Dyskinesia: Reversible and Irreversible
53 Citations1985Dympna Casey
Control of psychosis and improvement of TD during low-dose neuroleptic treatment suggest the antipsychotic and neurological effects of neuroleptics may involve different thresholds or mechanisms of action.
The British Journal of PsychiatryVentricular Enlargement in Schizophrenia
52 Citations1985Michael A. Reveley
CT scans of 19 unrelated chronic schizophrenics, all of monozygotic (MZ) twin birth, and 36 age-and-sex-matched normal twins from 18 MZ pairs were examined, and linear, planimetric, and semi-automated computerised methods distinguished schizophrenics from controls at approximately the same level of significance.
The British Journal of PsychiatryHeterogeneity of Tardive Dyskinesia
47 Citations1988William M. Glazer, Hal Morgenstern +2 more
It is suggested that orofacial and non-orofacial dyskinetic movements may involve distinct clinical syndromes of TD, each having a different set of prognostic and, possibly, aetiological determinants.
PubMedTardive dyskinesia: characterization and prevalence in a statewide system.
44 Citations1978Bell Rc, Smith Rc
Tardive dyskinesia significantly increased with age, and females had a slightly but significantly greater prevalence rate than males, and patients on multiple neuroleptic drugs had higher prevalence of moderately severe dysKinesia.
Cambridge University Press eBooksTardive dyskinesia and affective disorder
38 Citations1996G. Gárdos, Jonathan Cole
Psychological MedicineThe significance of subtyping tardive dyskinesia: a study of prevalence and associated factors
37 Citations1989Oye Gureje
Length of hospitalization correlated significantly with orofacial dyskinesia, cumulative duration of exposure to high-potency neuroleptics and number of ECTs received were significantly associated with appendicular TD, and neither age nor sex correlated with either of the subsyndromes.
PubMed[Tardive dyskinesia and affective disorders].
36 Citations1989Azorin Jm, P Thermoz
The authors analyse the relations between tardive dyskinesias and affective disorders on the basis of epidemiological, clinical and biological arguments and develop some hypotheses concerning the explanation of these relations.
The British Journal of PsychiatryMortality and Facial Dyskinesia
35 Citations1986H. A. McClelland, D. Dutta +2 more
Mild facial dyskinesia in functional disorders was not associated with reduced life expectancy and may be attributable to the general effects of ageing rather than to a specific pathological process.
The British Journal of PsychiatryTardive Dyskinesia: Fluctuating Patient or Fluctuating Rater
32 Citations1984J. A. Bergen, David Griffiths +2 more
The unexpected finding was that within-rater variability dominated within-patient variability.
Schizophrenia BulletinIs There a Tardive Dysmentia?
29 Citations1983I. C. Wilson, James C. Garbutt +4 more
It is the hypothesis that tardive dysmentia contributes to the changing course of schizophrenia and occurs after long-term treatment with antipsychotic drugs.
Psychopharmacology seriesInvoluntary Disorders of Movement in Chronic Schizophrenia — The Role of the Illness and Its Treatment
28 Citations1985D. G. Cunningham Owens
It is suggested that in the context of Schizophrenia neuroleptic drugs may act to promote what are features of the illness for some, and in the search for predisposing factors illness, as well as treatment variables, is worthy of consideration.